School of Medicine joins NIH initiative to expand use of AI in biomedical research
Washington University School of Medicine is joining the National Institutes of Health (NIH)’s Bridge2AI program, an estimated $130 million initiative. One project aims to develop a framework for using artificial intelligence to diagnose disease based on the sound of patients’ voices.
Evaluation of AI for medical imaging: A key requirement for clinical translation
To develop guidelines to evaluate artificial intelligence (AI) in nuclear-medicine imaging, an interdisciplinary team established by Richard L. Wahl, MD, director of Mallinckrodt Institute of Radiology (MIR) and led by Abhinav Jha, assistant professor at the McKelvey School of Engineering, published Recommendations for Evaluation of AI for Nuclear Medicine in the Journal of Nuclear Medicine.
New practical method of producing Airy beams could enhance ultrasound
Researchers led by the McKelvey School of Engineering’s Hong Chen recently invented a technique for generating ultrasound waves that can self-bend, like a rainbow.
Restoring movement after spinal cord injury focus of new research
Ismael Seáñez received a five-year $1 million grant from the National Institutes of Health (NIH) to lead interdisciplinary spinal cord injury research.
Low testosterone may increase risk of COVID-19 hospitalization for men
Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.
Push, pull or swirl: the many movements of cilia
Louis Woodhams and Phil Bayly’s team at the McKelvey School of Engineering built a model to better understand how certain cilia — tiny, hairlike structures throughout our body — beat.
WashU Medicine, BJC HealthCare partner with new company to accelerate lifesaving research
Washington University School of Medicine and BJC HealthCare are partnering with CuriMeta, a new company based in St. Louis, that will accelerate lifesaving research in the fight against chronic and acute diseases.
Modified nucleotides used in COVID-19 vaccines work as designed
Biologists in the laboratory of Hani Zaher in Arts & Sciences examined the modified nucleotides used in COVID-19 vaccines. The modifications faithfully produce the protein products as designed, a welcome sign for future RNA therapeutics.
Modeling personalized medicine for neurocritical illness
ShiNung Ching and collaborators are working with a $1 million NIH grant to predict and prevent some injuries related to neurological illnesses.
Lu studies potential benefits of AI in health care
Chenyang Lu at the McKelvey School of Engineering is evaluating the potential use of artificial intelligence to benefit patients’ health — and doctors’ well-being.
Older Stories